Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
RESEARCH TOOLSreports
Arcadia Biosciences (RKDA) Stock Price & Analysis
456 Followers
RKDA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.85 - $5.60
Previous Close$3
Volume6.42K
Average Volume (3M)26.27K
Market Cap
$4.09M
Enterprise Value-$6.68M
Total Cash (Recent Filing)$11.64M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Aug 14, 2024EPS Estimate
$1.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.29
Shares Outstanding1,362,840
10 Day Avg. Volume6,408
30 Day Avg. Volume26,269
Standard Deviation0.39
R-Squared0.00870
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.27
Price to Sales (P/S)0.41
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.22
Enterprise Value/Gross Profit-3.29
Enterprise Value/Ebitda0.33
Forecast
1Y Price Target
$9.00Price Target Upside198.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Arcadia Biosciences News
PremiumCompany Announcements
Arcadia Biosciences Shuffles Executive Team, Approves Bonuses
PremiumPre-Earnings
Is RKDA a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Growth And DistributionZola has seen 10%+ growth over the past few quarters, a trend which should accelerate as distribution is more than doubling this quarter.
New ProductsZola coconut water has two new flavors—pineapple and lime—which are 100% natural, no sugar added, and non-GMO.
Strategic TransactionsTwo separate transactions reshaped Arcadia overwhelmingly for the better.
Bears Say
DivestmentThe company has effectively divested one of its flagship brands, transforming it into a consumer products company focusing on the Zola Coconut Water franchise.
Price TargetThe price target has been lowered to $6 from $10 to reflect the impact of the loss of the GoodWheat franchise and the lack of visibility regarding the durability of revenue growth from sales of coconut water.
Revenue MissArcadia Biosciences reported 4Q23 revenue of $0.8M, significantly missing the revenue estimate of $1.8M.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RKDA FAQ
What was Arcadia Biosciences’s price range in the past 12 months?
Arcadia Biosciences lowest stock price was $1.85 and its highest was $5.60 in the past 12 months.
What is Arcadia Biosciences’s market cap?
Currently, no data Available
When is Arcadia Biosciences’s upcoming earnings report date?
Arcadia Biosciences’s upcoming earnings report date is Aug 14, 2024 which is in 39 days.
How were Arcadia Biosciences’s earnings last quarter?
Arcadia Biosciences released its earnings results on May 09, 2024. The company reported -$1.78 earnings per share for the quarter, beating the consensus estimate of -$2.215 by $0.435.
Is Arcadia Biosciences overvalued?
According to Wall Street analysts Arcadia Biosciences’s price is currently Undervalued.
Does Arcadia Biosciences pay dividends?
Arcadia Biosciences does not currently pay dividends.
What is Arcadia Biosciences’s EPS estimate?
Arcadia Biosciences’s EPS estimate is $1.55.
How many shares outstanding does Arcadia Biosciences have?
Arcadia Biosciences has 1,362,840 shares outstanding.
What happened to Arcadia Biosciences’s price movement after its last earnings report?
Arcadia Biosciences reported an EPS of -$1.78 in its last earnings report, beating expectations of -$2.215. Following the earnings report the stock price went down -0.962%.
Which hedge fund is a major shareholder of Arcadia Biosciences?
Among the largest hedge funds holding Arcadia Biosciences’s share is Ardsley Advisory Partners. It holds Arcadia Biosciences’s shares valued at N/A.
---
Arcadia Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (198.07% Upside)
$9.00 (198.07% Upside)
Blogger Sentiment
Neutral
RKDA Sentiment 50%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.01%
12-Months-Change
Fundamentals
Return on Equity
-48.87%
Trailing 12-Months
Asset Growth
-47.23%
Trailing 12-Months
Company Description
Arcadia Biosciences
Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.
---
RKDA Earnings Call
Q1 2024
0:00 / 0:00
---
RKDA Stock 12 Month Forecast
Average Price Target
$9.00
▲(198.07% Upside)
Technical Analysis
Best Analysts Covering RKDA
1 Year
1 Year Success Rate
4/26 ratings generated profit
1 Year Average Return
-36.48%
reiterated a buy rating last month
Copying Ben Klieve's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -36.48% per trade.
---